Asset Details
Do you wish to reserve the book?
Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model
Do you wish to request the book?
Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model
2015
Overview
Rationale
Seizures occur when the excitability of brain circuits is not sufficiently restrained by inhibitory mechanisms. Although modafinil is reported to reduce GABA-activated currents and extracellular GABA levels in the brain, the drug exerts anticonvulsant effects in animal studies.
Objectives
The aim of this study was to determine the effects of modafinil and its metabolites (sulfone and carboxylic acid) on the anticonvulsant action of four classical antiepileptic drugs (AEDs)—carbamazepine (CBZ), phenobarbital (PB), phenytoin (PHT), and valproate (VPA).
Methods
Anticonvulsant activity was assessed with the maximal electroshock seizure threshold (MEST) test and MES test in mice. Brain concentrations of AEDs were measured to ascertain any pharmacokinetic contribution to the observed anticonvulsant effects.
Results
Intraperitoneal injection of 75 mg kg
−1
of modafinil or its metabolites significantly elevated the threshold for electroconvulsions in mice, whereas 50 mg kg
−1
of each compound enhanced the anticonvulsant activity of CBZ, PHT, and VPA, but not that of PB. A 25-mg kg
−1
dose of modafinil or its sulfone metabolite enhanced anticonvulsant activity of VPA. Modafinil and its metabolites (50 mg kg
−1
) did not alter total brain concentrations of PB and VPA but did elevate CBZ and PHT.
Conclusions
Enhancement of anticonvulsant actions of VPA by modafinil in the mouse MES model is a pharmacodynamic effect. Collectively, our data suggest that modafinil may be a safe and beneficial adjunct to the therapeutic effects of AEDs in human patients.
Publisher
Springer Berlin Heidelberg,Springer,Springer Nature B.V
Subject
/ Anticonvulsants - pharmacokinetics
/ Anticonvulsants - pharmacology
/ Avoidance Learning - drug effects
/ Benzhydryl Compounds - pharmacology
/ Biomedical and Life Sciences
/ Carbamazepine - pharmacokinetics
/ Carbamazepine - pharmacology
/ Central Nervous System Stimulants - pharmacology
/ Dose-Response Relationship, Drug
/ Drugs
/ Epilepsy
/ Male
/ Mice
/ Phenobarbital - pharmacokinetics
/ Phenobarbital - pharmacology
/ Phenytoin - pharmacokinetics
/ Psychomotor Performance - drug effects
/ Rodents
/ Seizures - prevention & control
